Centessa Pharmaceuticals plc ADR’s recent filing unveils that its Officer HUSSAIN IQBAL J acquired Company’s shares for reported $0.1 million on Feb 18 ’25. In the deal valued at $17.07 per share,6,000 shares were bought.
Then, Anderson Karen M. sold 30,526 shares, generating $580,797 in total proceeds. Upon selling the shares at $19.03, the Chief People Officer now owns 54,322 shares.
Before that, Anderson Karen M. sold 429 shares. Centessa Pharmaceuticals plc ADR shares valued at $8,147 were divested by the Chief People Officer at a price of $18.99 per share. As a result of the transaction, Anderson Karen M. now holds 54,322 shares, worth roughly $0.88 million.
TD Cowen initiated its Centessa Pharmaceuticals plc ADR [CNTA] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in mid September from “an Equal-weight” to “an Overweight”. B. Riley Securities began covering CNTA with “Buy” recommendation on September 19, 2024. Oppenheimer started covering the stock on July 18, 2024. It rated CNTA as “an Outperform”.
Price Performance Review of CNTA
On Tuesday, Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA] saw its stock fall -4.75% to $16.26. Over the last five days, the stock has lost -8.60%. Centessa Pharmaceuticals plc ADR shares have fallen nearly -2.93% since the year began. Nevertheless, the stocks have risen 59.72% over the past one year. While a 52-week high of $19.09 was reached on 02/07/25, a 52-week low of $7.75 was recorded on 01/14/25. SMA at 50 days reached $16.87, while 200 days put it at $13.65.
Levels Of Support And Resistance For CNTA Stock
The 24-hour chart illustrates a support level at 15.42, which if violated will result in even more drops to 14.59. On the upside, there is a resistance level at 17.28. A further resistance level may holdings at 18.31. The Relative Strength Index (RSI) on the 14-day chart is 44.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.32, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 80.17%. Stochastics %K at 35.66% indicates the stock is a holding.
